參考文獻 |
1. F. Goos, and H. J. A. d. P. Hänchen, ”Ein neuer und fundamentaler Versuch zur Totalreflexion,” 436, 333-346 (1947).
2. F. Goos, and H. J. A. d. P. Lindberg‐Hänchen, ”Neumessung des strahlversetzungseffektes bei totalreflexion,” 440, 251-252 (1949).
3. I. J. R. S. o. L. Newton, ”1704. Opticks: or, a treatise of the reflexions, refractions, inflexions and colours of light.”
4. K. J. A. d. P. Artmann, ”Berechnung der Seitenversetzung des totalreflektierten Strahles,” 437, 87-102 (1948).
5. R. H. J. J. Renard, ”Total reflection: a new evaluation of the Goos–Hänchen shift,” 54, 1190-1197 (1964).
6. B. Liedberg, C. Nylander, I. J. B. Lundström, and Bioelectronics, ”Biosensing with surface plasmon resonance—how it all started,” 10, i-ix (1995).
7. H. Im, A. Lesuffleur, N. C. Lindquist, and S.-H. J. A. c. Oh, ”Plasmonic nanoholes in a multichannel microarray format for parallel kinetic assays and differential sensing,” 81, 2854-2859 (2009).
8. I. Alves, C. Park, V. J. J. C. P. Hruby, and P. Science, ”Plasmon resonance methods in GPCR signaling and other membrane events,” 6, 293-312 (2005).
9. P. J. S. Singh, and a. B. Chemical, ”SPR biosensors: historical perspectives and current challenges,” 229, 110-130 (2016).
10. S. Patskovsky, V. Latendresse, A.-M. Dallaire, L. Doré-Mathieu, and M. J. A. Meunier, ”Combined surface plasmon resonance and impedance spectroscopy systems for biosensing,” 139, 596-602 (2013).
11. T. Viitala, N. Granqvist, S. Hallila, M. Raviña, and M. J. P. o. Yliperttula, ”Elucidating the signal responses of multi-parametric surface plasmon resonance living cell sensing: a comparison between optical modeling and drug–MDCKII cell interaction measurements,” 8, e72192 (2013).
12. S.-P. Ng, C.-M. L. Wu, S.-Y. Wu, H.-P. Ho, S. J. B. Kong, and Bioelectronics, ”Differential spectral phase interferometry for wide dynamic range surface plasmon resonance biosensing,” 26, 1593-1598 (2010).
13. W. DiPippo, B. J. Lee, and K. J. O. e. Park, ”Design analysis of doped-silicon surface plasmon resonance immunosensors in mid-infrared range,” 18, 19396-19406 (2010).
14. C. Caucheteur, V. Voisin, and J. J. O. e. Albert, ”Near-infrared grating-assisted SPR optical fiber sensors: design rules for ultimate refractometric sensitivity,” 23, 2918-2932 (2015).
15. E. E. J. P. R. Hall, ”The penetration of totally reflected light into the rarer medium,” 15, 73 (1902).
16. J. Picht, Zur Theorie der Totalreflexion (Akademie-Verlag, 1956).
17. C. V. J. A. d. P. Fragstein, ”Zur Seitenversetzung des totalreflektierten Lichtstrahles.(Mit 3 Abbildungen),” 439, 271-278 (1949).
18. C. Schaefer, and R. J. A. d. P. Pich, ”Ein Beitrag zur Theorie der Totalreflexion,” 422, 245-266 (1937).
19. H. Raether, ”Surface plasmons on smooth surfaces,” in Surface plasmons on smooth and rough surfaces and on gratings(Springer, 1988), pp. 4-39.
20. J. D. Jackson, ”Classical electrodynamics,” (AAPT, 1999).
21. D. R. Corson, P. Lorrain, and F. J. A. J. o. P. Van Name Jr, ”Introduction to electromagnetic fields and waves,” 31, 556-556 (1963).
22. X. Yang, D. Liu, and W. Xie, ”High-sensitivity optical sensor based on surface plasmon resonance enhanced Goos-Hänchen shift,” in 2006 Conference on Optoelectronic and Microelectronic Materials and Devices(IEEE2006), pp. 74-77.
23. A. J. Z. N. P. Alzheimer, ”Uber eine eigenartige Erkrankung der Hirnrinde,” 18, 177-179 (1907).
24. A. J. A. D. A. D. Alzheimer, ”About a peculiar disease of the cerebral cortex,” 1, 8 (1987).
25. K. Maurer, and U. Maurer, Alzheimer: The Life of a Physician and the Career of a Disease (Columbia University Press, 2003).
26. A. Burns, and S. J. B. B. m. j. Iliffe, ”Alzheimer′s disease,” 338, 467-471 (2009).
27. W. H. Organization, ”Dementia. Fact sheet, Updated December 2017,” (2017).
28. P. D. Meek, E. K. McKeithan, G. T. J. P. T. J. o. H. P. Schumock, and D. Therapy, ”Economic considerations in Alzheimer′s disease,” 18, 68-73 (1998).
29. A. Wimo, L. Jonsson, B. J. D. Winblad, and g. c. disorders, ”An estimate of the worldwide prevalence and direct costs of dementia in 2003,” 21, 175-181 (2006).
30. D. Hsu, and G. J. C. A. R. A Marshall, ”Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward,” 14, 426-440 (2017).
31. M. S. Chong, and S. J. T. L. N. Sahadevan, ”Preclinical Alzheimer′s disease: diagnosis and prediction of progression,” 4, 576-579 (2005).
32. N. Sharma, A. N. J. J. o. c. Singh, and d. r. JCDR, ”Exploring biomarkers for Alzheimer’s disease,” 10, KE01 (2016).
33. O. Zanetti, S. Solerte, F. J. A. o. g. Cantoni, and geriatrics, ”Life expectancy in Alzheimer′s disease (AD),” 49, 237-243 (2009).
34. P. Mölsä, R. Marttila, and U. J. A. n. s. Rinne, ”Long‐term survival and predictors of mortality in Alzheimer′s disease and multi‐infarct dementia,” 91, 159-164 (1995).
35. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, H. M. J. A. s. Arrighi, and dementia, ”Forecasting the global burden of Alzheimer’s disease,” 3, 186-191 (2007). |